Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q2 2023, worth a total value of $32.3m. The $32.3m acquisition of Pill Club by Nurx was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q2 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, virtual care-related deal activity decreased by 93% in Q2 2023 compared with the previous quarter’s total of $431.4m. Related deal volume decreased by 57% in Q2 2023 versus the previous quarter.
The top-ranked legal advisors supporting these M&A deals in Q2 2023 were Greenberg Traurig; Morrison Foerster; Sheppard, Mullin, Richter & Hampton with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2023 – Thematic Intelligence, buy the report here.